Werner Baumann, Bayer CEO (Sascha Steinbach/picture-alliance/dpa/AP Images)
Bayer bails on chronic cough drug from Evotec, putting the kibosh on lead med in multi-target collaboration
Bayer and discovery outfit Evotec have long been bosom buddies, cycling through partnerships for the better part of a decade. But now, Bayer is dumping …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
